Anlon Healthcare Q1 Results FY27: Net Profit at Rs 8 Cr for June 2026 Quarter

Key Takeaways

• Anlon Healthcare's revenue for the June 2026 quarter came in at Rs 87 Cr, not meaningful for a year-on-year comparison, since the year-ago base was nil.
• Anlon Healthcare came in at a consolidated net profit of Rs 8 Cr, with no comparable year-ago base disclosed.
• Gross profit was reported at Rs 14 Cr for the quarter.
• The stock traded at Rs 14.52 on 30 July 2026, down 8.56% during the session.

If you are searching for Anlon Healthcare Q1 results FY27, here is the direct answer: Anlon Healthcare reported consolidated revenue of Rs 87 Cr and a net profit of Rs 8 Cr for the quarter ended 30 June 2026, not meaningful for a year-on-year comparison, since the year-ago base was nil. The rest of this article expands on that answer with the full revenue and profit breakdown, what changed compared with Q1 FY26, how the stock reacted, and what to watch next, so you do not need to piece it together from multiple sources.

Prepared by Ankit Jaiswal, Senior Research Analyst at Univest, this review of the Anlon Healthcare Q1 results FY27 is based on figures disclosed in the company's exchange filing for the June 2026 quarter.

Click Here – Get Free Investment Predictions

Anlon Healthcare Q1 Results FY27: Key Numbers at a Glance

Metric	Q1 FY27	Q1 FY26	YoY Change
Revenue	Rs 87 Cr	Rs 0 Cr	NA
Gross Profit	Rs 14 Cr	Rs 0 Cr	NA
Net Profit	Rs 8 Cr	Rs 0 Cr	NA

All figures in the Anlon Healthcare Q1 results FY27 table above are on a consolidated basis for the quarter ended 30 June 2026, compared with Q1 FY26. This is the core data set behind the Anlon Healthcare Q1 results FY27 search.

Anlon Healthcare Q1 Results FY27: What Drove Revenue

Revenue for Anlon Healthcare in Q1 FY27 was Rs 87 Cr. A year-on-year comparison is not meaningful here because the company's reported base for Q1 FY26 was nil, so this quarter effectively marks a fresh reporting baseline.

Anlon Healthcare Q1 Results FY27: Profitability Breakdown

Anlon Healthcare came in at a consolidated net profit of Rs 8 Cr, with no comparable year-ago base disclosed in Q1 FY27. Gross profit for the quarter was Rs 14 Cr.

The broadly consistent movement between gross profit and net profit in the Anlon Healthcare Q1 results FY27 suggests the quarter's profit performance is being driven mainly by core operations rather than one-off or below-the-line items.

Stock Price Reaction to the Anlon Healthcare Q1 Results FY27

Anlon Healthcare shares traded at Rs 14.52 on 30 July 2026, down 8.56% during the session. If your search intent is specifically about the stock reaction rather than the raw numbers, this is the figure that answers it: the market's verdict weighed the revenue and profit results together, alongside broader market conditions on the day.

Talk to a SEBI Registered Investment Adviser Before You Invest

What the Anlon Healthcare Q1 Results FY27 Mean for Investors

The Anlon Healthcare Q1 results FY27 give investors three concrete data points: a revenue base of Rs 87 Cr, a net profit of Rs 8 Cr, and a year-on-year growth trajectory that either confirms or challenges the investment thesis for the stock. None of these numbers should be read in isolation from the detailed exchange filing, segment disclosures and management commentary that typically accompany results.

Comparing this quarter with peers in the pharmaceutical intermediates space is also useful context. A company can post strong absolute growth and still lag its peer set, or post modest growth that is nonetheless best-in-class for its sector, so relative positioning matters as much as the standalone numbers in the Anlon Healthcare Q1 results FY27. Investors who track a basket of names in the same industry will typically get a clearer read on whether this quarter reflects a company-specific story or a broader sector trend.

Business Context Behind the Anlon Healthcare Q1 Results FY27

Anlon Healthcare operates in the pharmaceutical intermediates space, where demand cycles, input costs and competitive intensity all shape quarterly performance. The Anlon Healthcare Q1 results FY27 should be read against these sector-level dynamics rather than as a standalone number, since the same growth rate can carry very different implications depending on the underlying industry conditions.

Quarterly results are unaudited and subject to limited review, so any restatements or exceptional items disclosed in the notes to the Anlon Healthcare Q1 results FY27 can shift how the reported profit should be interpreted. Reading the full exchange filing alongside this summary remains the most reliable way to form a complete view, particularly for line items such as other income, exceptional items and tax adjustments that do not always show up in a headline summary.

Key Things to Watch After the Anlon Healthcare Q1 Results FY27

• Sequential trend: Whether the momentum in the Anlon Healthcare Q1 results FY27 carries into the September 2026 quarter or proves to be a one-off.
• Management commentary: Guidance on demand, margins and capital allocation for the rest of FY27.
• Sector conditions: Developments in the pharmaceutical intermediates space that could influence input costs, pricing power or competitive intensity.
• Corporate actions: Any dividend, capex or strategic announcements accompanying the results that signal management's confidence in the outlook.
• Balance sheet health: Debt levels, working capital trends and cash flow generation, which together determine how much flexibility Anlon Healthcare has to fund future growth.

Download the Univest iOS App or Univest Android App to track quarterly results, live prices and research updates in one place.

Conclusion

The Anlon Healthcare Q1 results FY27 show consolidated revenue of Rs 87 Cr and a net profit of Rs 8 Cr for the quarter ended 30 June 2026. The quarter's profit delivery keeps the near-term earnings narrative broadly intact. As Ankit Jaiswal notes, investors should track the next few quarterly prints and management commentary before drawing firm conclusions, and consult a SEBI registered investment adviser before acting on these results.

FAQs on Anlon Healthcare Q1 Results FY27

What was Anlon Healthcare's revenue in Q1 results FY27?

Ans. Anlon Healthcare's revenue in Q1 results FY27 was Rs 87 Cr, with no comparable year-ago base disclosed.

Did Anlon Healthcare make a profit or loss in Q1 FY27?

Ans. Anlon Healthcare reported a net profit of Rs 8 Cr in Q1 results FY27 on a consolidated basis for the quarter ended 30 June 2026.

What was Anlon Healthcare's gross profit in Q1 FY27?

Ans. Anlon Healthcare's gross profit in Q1 results FY27 was Rs 14 Cr.

When were the Anlon Healthcare Q1 results FY27 announced?

Ans. The Anlon Healthcare Q1 results FY27 were announced on 30 July 2026, covering the quarter ended 30 June 2026.

Did Anlon Healthcare shares go up or down after the Q1 results FY27?

Ans. Anlon Healthcare shares traded at Rs 14.52 on 30 July 2026, down 8.56% following the Q1 results FY27.

Were the Anlon Healthcare Q1 results FY27 consolidated or standalone?

Ans. The Anlon Healthcare Q1 results FY27 are on a consolidated basis, as reported in the company's exchange filing for the June 2026 quarter.

What should investors watch after Anlon Healthcare's Q1 results FY27?

Ans. Investors should watch the sequential trend into the September quarter, management commentary, sector-level conditions in the pharmaceutical intermediates space, and any corporate action announcements.

Are the Anlon Healthcare Q1 results FY27 a buy signal?

Ans. Quarterly results are a data point, not a recommendation. Investors should assess valuations, earnings quality and their own risk profile, and consult a SEBI registered investment adviser before investing.